Related Experiment Video

Updated: May 8, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

MicroRNA-16 inhibits bladder cancer proliferation by targeting Cyclin D1

Qi-Quan Jiang1, Bin Liu, Tao Yuan

  • 1Department of Urology, Affiliated Tongji Hospital, Tongji University, Shanghai, China.

Asian Pacific Journal of Cancer Prevention : APJCP
|September 3, 2013
PubMed

Insights

MicroRNA-16 (miR-16) is downregulated in bladder cancer and inhibits cell proliferation by negatively regulating cyclin D1. This finding highlights miR-16 as a key regulator in bladder cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNA-16 (miR-16) is implicated in cancer cell proliferation and apoptosis.
  • The specific role of miR-16 in bladder cancer pathogenesis is not well understood.

Purpose of the Study:

  • To investigate the expression and function of miR-16 in bladder cancer.
  • To elucidate the molecular mechanisms underlying miR-16's role in bladder cancer.

Main Methods:

  • Quantitative analysis of miR-16 expression in bladder cancer tissues versus normal tissues.
  • Cell proliferation assays in bladder cancer cell lines (TCHu-1) with enforced miR-16 expression or antisense miR-16 treatment.
  • Western blot analysis to assess the effect of miR-16 on cyclin D1 expression.

Main Results:

  • miR-16 expression was significantly downregulated in bladder cancer tissues compared to adjacent normal tissues.
  • Enforced expression of miR-16 inhibited bladder cancer cell proliferation, while antisense miR-16 promoted it.
  • miR-16 directly targets and negatively regulates cyclin D1 expression at the molecular level.

Conclusions:

  • miR-16 functions as a tumor suppressor in bladder cancer.
  • The downregulation of miR-16 contributes to increased cell proliferation in bladder cancer, partly through the upregulation of cyclin D1.
  • These findings identify miR-16 as a potential therapeutic target and biomarker for bladder cancer.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...